"Demand for appetite-suppressing drugs such as Mounjaro, Wegovy and Ozempic has surged since they were introduced into the Indian market this year. In the eight months since it was approved for sale, Mounjaro a jab that regulates blood sugar and suppresses appetite to help with diabetes and obesity is now India's highest-selling drug, overtaking antibiotics. Its commercial success has led its producer, the drug company Eli Lilly, to begin trials on a similar drug that works on suppressing appetite,"
"Rising urbanisation, sedentary lifestyles, and changing diets have made weight management a growing public health priority. This convergence of high unmet need, growing awareness and improving access to innovative therapies makes India a significant market for weight loss drugs."
"The drug company Novo Nordisk is also pushing for a share of the market. It launched Ozempic this month at the competitively low price of 8,800 rupees (73) for four jabs a month, compared with the 14,000 rupees (115) monthly cost of Mounjaro prices beyond the reach of the average Indian household. But by March next year, the drug company patents on many of these semaglutide drugs is due to expire in India. This will open the market to domestic companies who are developing their own cheaper versions, which are expected to flood the market and make prices more affordable."
Demand for appetite-suppressing drugs such as Mounjaro, Wegovy and Ozempic has surged since introduction to the Indian market, with Mounjaro becoming the country's highest-selling drug within eight months. Eli Lilly has begun trials on a similar appetite-suppressing drug, potentially available in pill form. Novo Nordisk launched Ozempic at a lower price than Mounjaro, while patent expirations next March are expected to allow domestic manufacturers to produce cheaper semaglutide versions. Experts forecast the Indian weight-loss drug market could reach $150bn annually by decade’s end amid rising obesity and diabetes pressures.
Read at www.theguardian.com
Unable to calculate read time
Collection
[
|
...
]